A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)

NCT01370603 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Atorvastatin
DRUG: Ezetimibe
DRUG: Ezetimibe/atorvastatin
DRUG: Placebo to atorvastatin
DRUG: Placebo to ezetimibe
DRUG: Placebo to ezetimibe/atorvastatin

Sponsor

Organon and Co